MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Quest Diagnostics Company Profile (NYSE:DGX)

Consensus Ratings for Quest Diagnostics (NYSE:DGX) (?)
Ratings Breakdown: 2 Sell Rating(s), 8 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $75.50 (3.50% downside)

Analysts' Ratings History for Quest Diagnostics (NYSE:DGX)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016Jyske BankDowngradeNeutral -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Morgan StanleyReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016MizuhoReiterated RatingBuy$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Credit SuisseReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016KeyBancReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Robert W. BairdReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016BarclaysBoost Price TargetEqual Weight$72.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016RBC CapitalBoost Price TargetSector Perform$70.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Goldman SachsBoost Price Target$71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016William BlairReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2015Wells FargoUpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Jefferies GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Deutsche BankDowngradeBuy -> Hold$77.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Bank of AmericaDowngradeNeutral -> Underperform$71.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Citigroup Inc.Boost Price TargetNeutral$65.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Craig HallumDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015Raymond JamesUpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014Maxim GroupBoost Price TargetBuy$68.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Quest Diagnostics (NYSE:DGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
4/21/2016Q116$1.12$1.12$1.82 billion$1.86 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$1.19$1.19$1.85 billion$1.85 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315$1.26$1.28$1.89 billion$1.88 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$1.23$1.25$1.93 billion$1.93 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$1.04$1.05$1.85 billion$1.84 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$1.04$1.08$1.85 billion$1.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314$1.08$1.10$1.87 billion$1.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214$1.06$1.08$1.88 billion$1.90 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q114$0.89$0.84$1.75 billion$1.75 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q413$0.93$0.97$1.74 billion$1.76 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313$1.20$1.02$1.84 billion$1.79 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2013Q2 2013$1.10$1.06$1.84 billion$1.82 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2013Q1 2013$1.03$0.89$1.86 billion$1.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2013Q4 2012$1.02$1.01$1.83 billion$1.77 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2012$1.18$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2012$1.17$1.17ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2012$1.01$1.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2012$1.06$1.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$1.11$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2011$1.12$1.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011$1.01$1.00ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2011$0.91$0.98ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Quest Diagnostics (NYSE:DGX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.00$1.15$1.09
Q2 20165$1.31$1.33$1.32
Q3 20164$1.34$1.40$1.38
Q4 20164$1.25$1.30$1.27
Q1 20172$1.17$1.19$1.18
Q2 20172$1.39$1.43$1.41
Q3 20172$1.40$1.44$1.42
Q4 20172$1.37$1.39$1.38
(Data provided by Zacks Investment Research)
Current Dividend Information for Quest Diagnostics (NYSE:DGX)
Annual Dividend:$1.60
Dividend Yield:2.04%
Payout Ratio:31.37%
Dividend Growth:29.30% (3 Year Average)

Dividend History for Quest Diagnostics (NYSE:DGX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/18/2016quarterly$0.402.1%7/1/20167/6/20167/20/2016Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016quarterly$0.402.31%4/4/20164/6/20164/20/2016Tweet This Announcement  Share This Announcement on StockTwits
12/4/2015quarterly$0.382.22%1/8/20161/12/20161/27/2016Tweet This Announcement  Share This Announcement on StockTwits
8/18/2015quarterly$0.382.07%10/2/201510/6/201510/21/2015Tweet This Announcement  Share This Announcement on StockTwits
5/15/2015quarterly$0.382.09%7/6/20157/8/20157/22/2015Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015quarterly$0.382.13%4/6/20154/8/20154/22/2015Tweet This Announcement  Share This Announcement on StockTwits
12/4/2014quarterly$0.332.03%1/9/20151/13/20151/28/2015Tweet This Announcement  Share This Announcement on StockTwits
8/15/2014quarterly$0.332.14%10/3/201410/7/201410/22/2014Tweet This Announcement  Share This Announcement on StockTwits
5/21/2014quarterly$0.332.3%7/7/20147/9/20147/23/2014Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014quarterly$0.332.51%4/4/20144/8/20144/23/2014Tweet This Announcement  Share This Announcement on StockTwits
12/6/2013quarterly$0.301.99%1/3/20141/7/20141/22/2014Tweet This Announcement  Share This Announcement on StockTwits
8/20/2013quarterly$0.302.03%9/27/201310/1/201310/16/2013Tweet This Announcement  Share This Announcement on StockTwits
5/21/2013quarterly$0.301.96%6/28/20137/2/20137/17/2013Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013quarterly$0.302.14%3/28/20134/2/20134/16/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Quest Diagnostics (NYSE:DGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/27/2016Catherine T DohertySVPSell47,334$77.27$3,657,498.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Jenne K BritellDirectorSell8,000$75.68$605,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Everett CunninghamSVPSell56,312$76.26$4,294,353.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Everett CunninghamSVPSell50,447$76.00$3,833,972.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016Catherine T DohertySVPSell29,550$74.45$2,199,997.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Michael E PrevoznikSVPSell3,261$71.16$232,052.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2015Daniel StanzioneDirectorSell8,000$70.97$567,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Gail R WilenskyDirectorSell8,000$72.34$578,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015John B ZieglerDirectorSell8,000$71.88$575,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Thomas F BongiornoVPSell3,000$71.50$214,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Jon R CohenSVPSell160,029$63.13$10,102,630.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Catherine T DohertySVPSell25,000$60.12$1,503,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Michael E PrevoznikSVPSell14,377$61.01$877,140.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Jenne K BritellDirectorSell8,000$62.37$498,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Michael E PrevoznikSVPSell16,384$62.51$1,024,163.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014John C Md BaldwinDirectorSell8,000$62.31$498,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Thomas F BongiornoVPSell4,000$61.72$246,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014John B ZieglerDirectorSell8,000$61.90$495,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014John ZieglerDirectorSell2,973$57.65$171,393.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014Gary PfeifferDirectorSell10,000$55.95$559,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Mark GuinanCFOBuy4,000$55.51$222,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Jenne BritellDirectorSell10,000$52.74$527,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Michael PrevoznikSVPSell2,860$52.26$149,463.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Gail WilenskyDirectorSell30,000$52.93$1,587,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2014Timothy MainDirectorBuy5,000$50.71$253,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Thomas F BongiornoVPSell16,667$62.49$1,041,520.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Thomas F BongiornoVPSell6,000$59.00$354,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/25/2013Gary M PfeifferDirectorSell2,000$58.10$116,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2013Catherine DohertySVPSell43,334$62.00$2,686,708.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Catherine DohertySVPSell33,000$59.85$1,975,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013John ZieglerDirectorSell1,953$59.45$116,105.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Thomas BongiornoVPSell10,864$59.33$644,561.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013Jenne K BritellDirectorSell4,200$58.99$247,758.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Michael E PrevoznikSVPSell126,667$62.64$7,934,420.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013John B ZieglerDirectorSell31,362$62.00$1,944,444.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013John C Md BaldwinDirectorSell1,214$59.41$72,123.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2013John B ZieglerDirectorSell1,470$58.35$85,774.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2013Gary M PfeifferDirectorSell10,000$60.00$600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2012Robert HagemannCFOSell46,667$64.00$2,986,688.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2012Stephen H RusckowskiCEOBuy5,000$59.34$296,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Quest Diagnostics (NYSE:DGX)
DateHeadline
06/27/16 06:38 AMQuest Diagnostics Poised on Strategic Tie-Ups, New Launches -
06/26/16 03:13 PMMost important stocks of the day: Quest Diagnostics Inc. (NYSE:DGX) - Twin County News
06/25/16 03:26 PMDGX Dividend Yield Pushes Past 2%
06/25/16 07:28 AMHealthcor Management LP Increased Quest Diagnostics INC (NYSE:DGX) by $94.10 Million as Shares Rose - Press Telegraph
06/24/16 10:21 AMQuest Diagnostics Incorporated (DGX) is Trading Higher on Unusual Volume for June 22
06/23/16 02:31 PMAnalysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and Laboratory Corporation Of ... - Markets.co
06/23/16 02:31 PMIs Quest Diagnostics Inc (NYSE:DGX) a Valuable Stock? - Street Report
06/20/16 03:32 PMQuest Diagnostics Signs 130,000-SF HQ Lease in Secaucus
06/20/16 09:51 AMQuest Diagnostics : to Relocate Headquarters to 500 Plaza Drive in Secaucus, NJ
06/20/16 07:29 AMQuest Diagnostics, Inc. breached its 50 day moving average in a Bearish Manner : DGX-US : June 20, 2016 -
06/20/16 04:00 AMQuest Diagnostics to Relocate Headquarters to 500 Plaza Drive in Secaucus, NJ - [PR Newswire] - NORWALK, Conn., June 20, 2016 /PRNewswire/ -- Marcus Partners, a value-oriented real estate investor, announced today that Quest Diagnostics Incorporated, (NYSE: DGX), the world's leading provider of diagnostic ...
06/18/16 03:18 PMDon't Miss This Chance To Buy Quest Diagnostics Inc (NYSE:DGX) - Street Report
06/17/16 06:42 PMFDA Grants Emergency Authorization for Hologic Zika Test -
06/16/16 03:37 PMStock Performance to Track: Quest Diagnostics Inc. (NYSE:DGX) - News Oracle
06/16/16 03:37 PMMarket Moving Stocks Update: Quest Diagnostics Inc. (NYSE:DGX), Horizon Pharma plc (NASDAQ:HZNP) - Beacon Chronicle
06/16/16 07:57 AMQuest Diagnostics : and Safeway Team to Offer Convenient Diagnostic Testing to Customers in More States
06/15/16 03:41 PMComprehensive Report on: Kimberly-Clark Corporation (NYSE:KMB), Quest Diagnostics Inc. (NYSE:DGX) - Beacon Chronicle
06/15/16 01:59 PMUnsafe Lead Levels in Children Found in Numerous Regions of the United States, Finds New Study in Journal of Pediatrics - [at noodls] - MADISON, N.J., June 15, 2016 /PRNewswire/ -- Despite four decades of public health efforts to minimize children's exposure to lead, high percentages of unsafe blood lead levels are still found in children ...
06/14/16 03:29 PMQuest Diagnostics : New Study of Physicians and Health Plan Executives Reveals Actions Needed to Accelerate Value-Based Care
06/14/16 08:26 AMHere's my favorite 25 stocks
06/14/16 07:04 AMNew Study of Physicians and Health Plan Executives Reveals Actions Needed to Accelerate Value-Based Care - [PR Newswire] - MADISON, N.J., June 14, 2016 /PRNewswire/ -- A new study of physicians and health plan executives suggests that the complexity of quality measures and physicians' lack of access to patient data at the point of care are barriers to the healthcare industry's adoption of value-based care. The study, commissioned by Quest Diagnostics (DGX) and Inovalon (INOV), also reveals physicians and health plan executives hold starkly different perceptions about the importance of, and impediments to, value-based care adoption, pointing to opportunities for greater physician, health system and health plan collaboration.
06/13/16 03:24 PMWalgreens cuts ties with Theranos; to close centers in Arizona
06/13/16 09:16 AMWalgreens ends relationship with Theranos, in-store centers closing immediately
06/13/16 09:16 AMQuest Diagnostics Inc. (NYSE:DGX) Near to Lift Curtain on June 2016 Earnings
06/12/16 08:41 PMWalgreens Cuts Ties With Theranos, Closing 40 Wellness Centers -
06/11/16 09:20 AMTwo Stocks within Analysts Review: Quest Diagnostics Incorporated (NYSE:DGX) , The Medicines Company (NASDAQ ... - Street Updates
06/09/16 09:38 PMQuest Diagnostics Inc. (NYSE:DGX) Fundamental Star Rating Report - CML News
06/09/16 03:38 PMEarnings Expectation Watch List: Quest Diagnostics Inc. (NYSE:DGX), Timmins Gold Corp. (NYSEMKT:TGD) - Beacon Chronicle
06/09/16 03:38 PMQuest Diagnostics Inc (NYSE:DGX) near 52-week high, short interest stable - Street Report
06/07/16 09:15 PMQUEST DIAGNOSTICS INC. (NYSE:DGX) Financial Condition Compared to S&P 500 - CML News
06/06/16 03:27 PMPreview of Analysts Recommendation: Bristol-Myers Squibb Company (NYSE:BMY) , Quest Diagnostics Incorporated ... - Street Updates
06/06/16 03:27 PMAnalyst Overview: Quest Diagnostics Inc. (NYSE:DGX), Precision Drilling Corporation (NYSE:PDS) - Beacon Chronicle
06/06/16 10:56 AMQuest keeping headquarters in New Jersey after tax credits -
06/06/16 04:23 AMHC Stocks Reports Analysis: Quest Diagnostics Inc (NYSE:DGX), Tenet Healthcare Corp (NYSE:THC) - share market updates (press release)
06/05/16 09:51 AMPerformance Review for Quest Diagnostics Inc. (NYSE:DGX) - HNN
06/03/16 03:49 PMAnalyst Overview: Quest Diagnostics Inc. (NYSE:DGX), Trinity Industries Inc. (NYSE:TRN) - Beacon Chronicle
06/03/16 03:49 PMMizuho Reiterates Buy Rating for Quest Diagnostics Inc (DGX) - Let Me Know About This
06/02/16 03:45 PMOn the Move Insider Trading: Quest Diagnostics Inc (NYSE:DGX) - The Point Review - The Point ReviewOn the Move Insider Trading: Quest Diagnostics Inc (NYSE:DGX)The Point ReviewQuest Diagnostics Inc (NYSE:DGX) insiders have most recently took part in a trading activity. On 5/23/2016 Davis J.E, SVP, Regional business sold 1,907 shares having total worth of $145,504 at the price of $76.30 per share, following the transaction a ...Quest Diagnostics Inc (NYSE:DGX) near 52-week high, short interest decreasingStreet ReportWhat Analyst's have to say about Quest Diagnostics Inc (NYSE:DGX)CWRU ObserverNotable Stocks within Investor Radar Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Quest Diagnostics ...Street UpdatesStreet Wise Report (press release) (blog) -Is stories -Risers & Fallersall 25 news articles »
06/02/16 03:32 PMPrince’s death casts light on America’s soaring prescription drug abuse -
06/02/16 12:24 PMFit Female College Athletes More Prone to Overreaching than Less Fit Ones, Putting Performance at Risk, Finds New Research Presented at American College of Sports Medicine Annual Meeting - [PR Newswire] - Researchers at Rutgers, The State University of New Jersey, reported that biomarker testing of female collegiate athletes on the Rutgers soccer and field hockey teams showed the athletes with better fitness at baseline testing exhibited heightened inflammation and muscle breakdown as early as the first half of the season. Researchers hypothesized that the athletes may be exhibiting early signs of overreaching due to higher work outputs and less rest and recovery in competitive games than those players who are visibly tiring. If left unaddressed, overreaching can lead to overtraining syndrome, in which an athlete trains beyond the body's ability to recover.
06/02/16 08:25 AMQuest Diagnostics To Speak At The Goldman Sachs 37th Annual Global Healthcare Conference - [at noodls] - MADISON, N.J., June 2, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman ...
06/01/16 03:47 PMQuest Diagnostics Inc (NYSE:DGX) near 52-week high, short interest decreasing - Street Report - Is storiesQuest Diagnostics Inc (NYSE:DGX) near 52-week high, short interest decreasingStreet ReportQuest Diagnostics Inc (NYSE:DGX) (Trend Analysis) shares were traded with a significant increase in volume. The stock closed last trading session at $77.17, down by -0.05%, with a volume of 1,701,017 shares against an average amount for the last three ...What Analyst's have to say about Quest Diagnostics Inc (NYSE:DGX)CWRU ObserverVigorous Gainers/Losers Roundup: Quest Diagnostics (NYSE:DGX), Workday (NYSE:WDAY), INC Research (NASDAQ ...Street Wise Report (press release) (blog)Moving Healthcare Stocks to Concentrate: CVS Health Corporation (NYSE:CVS) , Quest Diagnostics Incorporated ...Is storiesPR Newswire (press release) -Equities Focus -Finance Dailyall 11 news articles »
06/01/16 07:11 AMOne Year After Launch, BRCA Share™ Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk - [PR Newswire] - MADISON, N.J. and PARIS and BURLINGTON, N.C., June 1, 2016 /PRNewswire/ -- BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. BRCA Share was co-founded by Quest Diagnostics (DGX) and the French National Institute of Health and Medical Research (Inserm) in April 2015, with Laboratory Corporation of America® Holdings (LabCorp®) (LH) as the first commercial participant.
05/28/16 09:53 PMPerformance at a Glance on Quest Diagnostics Inc. (NYSE:DGX) - HNN - Performance at a Glance on Quest Diagnostics Inc. (NYSE:DGX)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Quest Diagnostics Inc. (NYSE:DGX)'s stock has performed at various points in its past. Currently, the ...and more »
05/27/16 05:04 PMHealthcare Trader's Buzzers: Depomed Inc (NASDAQ:DEPO), Quest Diagnostics Inc(NYSE:DGX) - NYSE Journal (press release) - Healthcare Trader's Buzzers: Depomed Inc (NASDAQ:DEPO), Quest Diagnostics Inc(NYSE:DGX)NYSE Journal (press release)On Thursday, Shares of Depomed Inc (NASDAQ:DEPO), added 0.20% and closed at $20.01 in the last trading session. The last trading range of the stock ranges between $19.56and $20.34. Depomed, recently issued the following statement in response to ...and more »
05/26/16 04:02 PMQUEST DIAGNOSTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme -
05/26/16 02:45 PMMoody's Upgrades One and Affirms Three Classes of JPMCC 2004-C3 -
05/26/16 11:17 AMQuest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk - [at noodls] - MADISON, N.J., May 26, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of three new cancer test services ...
05/26/16 07:10 AM7 Companies in the Fight to Defeat the Zika Virus -
05/25/16 04:40 PMStock Moving to Recent High: Quest Diagnostics Inc. (NYSE:DGX) - Wall Street Hints and News - Stock Moving to Recent High: Quest Diagnostics Inc. (NYSE:DGX)Wall Street Hints and NewsQuest Diagnostics Inc. (NYSE:DGX)'s stock has seen a steady move upward, reaching $77.48 on a recent bid, generating strong interest amongst investors and analysts alike. Shareholders are noting a Return on Investment (ROI) of 12.30%. Return on ...and more »
About Quest Diagnostics

Quest Diagnostics logoQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company's Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians' health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company's enterprise content management system for hospitals.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: DGX
  • CUSIP: 74834L10
Key Metrics:
  • Previous Close: $77.58
  • 50 Day Moving Average: $77.29
  • 200 Day Moving Average: $71.38
  • P/E Ratio: 15.03
  • P/E Growth: 1.97
  • Market Cap: $10.97B
  • Current Quarter EPS Consensus Estimate: $5.09 EPS
Additional Links:
Quest Diagnostics (NYSE:DGX) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha